You are here

Contact:
Wanda Moebius
202-434-7240
wmoebius@advamed.org
September 25, 2015

Ubl Steps Down as CEO of AdvaMed: Sixteen Years of Association Service Marked by Significant Growth

Washington, DC – AdvaMed Board Chairman Vincent A. Forlenza, chairman, CEO and president BD, released the following statement regarding Stephen J. Ubl, president and CEO of AdvaMed (the Advanced Medical Technology Association):

“AdvaMed’s Board of Directors has accepted Steve’s resignation as president and CEO of AdvaMed, effective Oct. 15. The Board wishes to express its deep appreciation for Steve’s leadership over his sixteen year involvement with the association, including the last 10 years as president and CEO.

“During Steve’s time at AdvaMed, the association experienced significant growth in membership, policy development capabilities as well as advocacy impact.  As CEO, he created dedicated divisions to address the unique needs of the diagnostics industry and emerging growth companies – AdvaMedDx and AdvaMed Accel, respectively. 

“He helped the industry proactively address the importance of ethics and responsible business practices through the development of a robust legal department to engage with member company attorneys. This work resulted in an enhanced AdvaMed Code of Ethics. Another significant advancement during his tenure was the expansion of the association’s international reach, including the recently opened China office and expanded emerging market capabilities. A key association milestone under Steve’s leadership was the creation of the nation’s leading medical technology conference, AdvaMed 2015, a premier event in health care.

“One of Steve’s key talents is his ability to identify and recruit top talent, and over the years he has built a very strong team. The experience of AdvaMed’s senior leadership team and AdvaMed’s actively engaged Board of Directors leaves it well positioned to continue our important work, helping to bring life-enhancing technologies to the patients we serve.

“We are in the process of undertaking a national search for Steve’s replacement. During the transition, AdvaMed’s Board of Directors will work closely with AdvaMed senior staff to advance repeal of the medical device tax and important regulatory reforms and efficiencies contained in the House and Senate’s 21st Century Cures and Healthier Americans initiatives, as well as successful negotiation of the next Medical Device User Fee Agreement (MDUFA).

“I know the Board joins me in thanking Steve for his significant contributions to the medical technology industry over the years, contributions that led directly to advancements in patient care. We wish him well in his new endeavors.”

# # #